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ABSTRACT 
Factors Influencing Surgeon Adoption of Technology in the Medical Device Industry 
by 
Sean Reynolds 
April 2020 
Chair: Naveen Donthu, Ph.D. 
Major Academic Unit: Doctorate in Business 
The medical device industry can be quite competitive, and companies that succeed tend to provide 
innovative solutions that are adopted by surgeons for clinical use in surgery. However, successful 
clinical adoption of technology is often problematic for some companies, and this research aims 
to determine which behavioral factors influence surgeon adoption of technology in the medical 
device industry. This empirical investigation uses the Technology Acceptance Model 2 (TAM2) 
to test the relationships between technology acceptance and variables that impact surgeon 
behavior. This research examines spine surgeons’ adoption of 3D-printed implants used in surgery, 
and the results suggest that subjective norms, job relevance, and output quality represent predictors 
of a positive intention to use technology, which denotes a positive influence on technology 
adoption. Environmental and economic hospital factors have a moderating effect on the 
relationship between intention to use and 3D-printed implant adoption. These results contribute to 
research by extending the framework of the TAM2 to clinical adoption while testing for additional 
factors that have not historically been measured. The results also provide practitioners with 
insights to create marketing campaigns to address the behavior variables that influence surgeon 
adoption of technology. 
INDEX WORDS: Theory of Reasoned Action, Theory of Planned Behavior, Technology 
Acceptance Model, TAM, TAM2, Surgeon, Adoption, Subjective Norm, Hospital Factors, 
xii 
 
Medical Devices, 3D Printing, Surgery, Perceived Usefulness, Perceived Ease of Use, 
Intention to Use, Behavioral Intent 
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I CHAPTER 1. INTRODUCTION 
I.1 Introduction to the Problem 
 Organizations consistently seek new ways to remain competitive amongst peers, and a 
competitive edge is often attained through the launch of new, innovative products (Tellis, Prabhu 
& Chandy, 2009; Clark & Guy, 1998). These new products are touted as being better than the 
norm and often may entail significant pricing to offset the research and development invested in 
designing the products. New, innovative products are unfortunately not necessarily adopted by 
their target consumer, which is evident across many industries but especially in healthcare, and 
more specifically, the medical device industry. The adoption of medical technology is not 
necessarily linear from the innovation process to adoption as there are factors that will impact the 
adoption process (Gelijns & Rosenberg, 1994). Surgeon users are often the target audience of this 
industry’s innovations and influence the success of these devices. The products are usually 
designed using surgeon input to address surgeon needs and promote adoption of these devices. 
Some technologies enjoy successful adoption from clinicians due to improved clinical outcomes, 
reduced operating times, greater efficiencies, or cost savings to the procedure (not necessarily the 
cost of the technology). The successful adoption of these products is necessary for the continued 
growth of some organizations, as companies spend significant research, development, and 
marketing funds to bring these products to market. However, strategic and tactical marketing plans 
can be arbitrary and conceptually flawed (Varadarajan, 2010). The marketing plan may be based 
on intuition. Targeting and success are measured based on the comparison of historical sales 
revenue of similar older products. Depending on the product, this “intuition” may be quantified 
and estimated based on variables such as surgeon age, the volume of surgical procedures, or 
industry influence. These sales and marketing plans generally follow the process for diffusion 
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models (Rogers, 2003) in which surgeon targets equate to “innovators,” and are projected to 
influence the “majority”. This approach does not always translate into increased sales (Mahajan & 
Muller, 1998). The product adoption can, unfortunately, be hit or miss. Although these models 
describe sales and marketing timing techniques, they do not provide insight into the decision 
process (Roback et al., 2007) by surgeons. Thus, sales and marketing techniques create a need for 
more defined ways to successfully target surgeons and determine what drives their adoption 
behaviors.  
Due to the constant addition of new technologies in the medical industry and specifically 
the spine industry, there needs to be a better understanding of why surgeons adopt certain 
technologies as opposed to others. Companies that launch these new products need to understand 
better the underpinnings regarding what influences surgeon adoption rates (Hatz et al., 2017). 
Thus, allowing marketing strategies to be better designed and implemented will help position these 
products for surgeons who are more willing to adopt new technologies. 
 Research has shown that there is a need for more sophisticated marketing managers who 
can more broadly influence new product success, performance, and profitability (Cake, 2010). 
However, these marketers also need more advanced insight into their customer base and into what 
drives their customers towards technology adoption. Customers may not wholly realize their exact 
needs and how the technology may assist them, so it is incumbent on marketing professionals to 
uncover new ways to identify these unarticulated motivations (Cake, 2010). This research seeks to 
explore these motivations and hopefully provide insight into surgeon factors that influence their 
adoption of technology. 
  This research investigates the factors that influence spine surgeon adoption of innovative 
technologies utilized in the spine sector of the medical device industry. This sector is the focus 
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because this surgical environment is currently ripe with access to new technologies that could 
impact spine surgeries globally. Surgeons often trial and adopt new technologies that affect how 
they operate. Many of these technologies are promoted by medical device companies to enable 
surgeons to operate quicker, more efficiently, more safely, and with improved clinical outcomes. 
There is occasionally clinical evidence to support these claims, but often there is none. As a result, 
surgeon adoption can be challenging as many surgeons may not adopt new technologies since they 
do not want to change current practices. Recent innovations such as three-dimensional printing 
(3DP), also known as additive manufacturing, has created new opportunities for spinal implant 
companies and provided surgeons with surgical implants and tools that could significantly impact 
successful patient recovery post-operatively. The possibilities for companies developing these 
innovations are numerous, such as the reduced cost of goods, improved research and development 
design timelines and new device creation that is difficult or impossible using traditional 
manufacturing processes (Tack et al., 2016). For surgeons and patients, these new 3D-printed 
implants and tools have the potential to improve clinical performance and outcomes, such as 
improved fusion rates in patients, which will aid in their surgical recovery (Kim et al., 2017). Many 
organizations within the medical device industry often target younger surgeons or surgeons with 
high surgical volumes, which assumes that these populations more readily adopt new technology. 
Approaches such as targeting high-volume users are chosen for business reasons; however, 
adopting surgeons’ reasons for selecting the technology is not always clear. This approach may 
ignore other variables that ultimately affect surgeon adoption, and they may adopt technology but 
discontinue use a few months later. This research intends to provide a more insightful and validated 
method of successfully marketing these new technologies and subsequent others to surgeons. The 
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focus of this research is on examining 3D-printing technology adoption among surgeons, including 
facilitators and barriers to technology adoption. 
I.2 Barriers to New Technology Adoption 
 New technology has always faced the challenge of potentially not being adopted, and 
usually, new technologies are associated with start-up organizations. If surgeon users do not adopt 
these new technologies, it can threaten a company’s survival. Large companies are not unscathed 
by non-adoption since they must account for the lost revenue. However, it should be noted that 
new, innovative devices typically originate from small companies.  
 What ultimately impacts new technology adoption? The literature has identified six 
barriers: cost, legality (regulatory), time, fear, usefulness, and complexity (Garrett et al., 2016; 
Gelijns et al., 1991, Chapter 6; Citron, 2011). Of these barriers, those most associated with the 
direct user include time, fear, usefulness, and complexity. The others are more organizationally 
based since hospitals are more concerned with cost and legality (regulatory approvals) (Egeland 
et al., 2017).  
Regarding the influences on the customer concerning time, if the technology takes too long 
to master, this will impact the adoption. Surgeons can be an impatient customer, and thus the 
technology must be straightforward. This is closely related to complexity since sophisticated 
technology runs the risk of slow adoption rates. Another aspect that minimizes adoption concerns 
is fear. In this litigious society, surgeons do not want to adopt technology that will harm their 
patients and ultimately impact their clinical practice. Thus, the technology must be vetted and 
proven (Lieberman & Wenger, 2004). Finally, usefulness represents the most critical aspect as the 
technology should provide clinical benefits to the surgical procedure and ultimately positively 
impact the patient’s clinical outcome (Hogaboam & Daim, 2018).  
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The barriers to new technology adoption can be overcome, but only if the concerns of the 
customers and organizations are addressed. Once these entities are satisfied, the technology’s 
“desirability, acceptability, feasibility can lead to adoptability” (Ulucanlar et al., 2013). 
I.3 3D Printing Technology 
The 3D-printed medical device market is projected to grow from $973M in 2018 to $3.69B 
by 2026, with a compounded annual growth rate of 18.2% (Kunsel & Sumant, 2019). The drivers 
of this growth include the applications and benefits that many in the medical arena find to be game-
changing. The historical benefit of 3D printing was rapid prototyping, but it has become a powerful 
manufacturing technology that allows for speed, customization, and minimization of waste (Ben-
Ner & Siemsen, 2017). This technology has allowed companies to manufacture devices that were 
traditionally impossible or cost-prohibitive to manufacture via the historical method of subtractive 
manufacturing (Kunsel & Sumant, 2019). Subtractive manufacturing involves milling or cutting 
material away from a solid block of material via a computer numerical control (CNC) machine. In 
additive manufacturing, products are constructed by depositing material in layers in a computer-
aided design (CAD) shape  
 
Figure 1 3D Printing Laser Process 
Source: 3D Systems 
and using lasers to bond the material (Figure 1). This process is completed layer by layer until the 
final product is complete. In recent years, the machinery used for additive manufacturing has 
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become much more affordable, thus accelerating the adoption of this technology for the 
manufacturing process (Figure 2).  
 
Figure 2 3D Printer, DMP Factory 350 
Source: 3D Systems 
Although this manufacturing process benefits the medical costs of goods (Ventola, 2014), 
it also provides benefits clinically, such as in surgical planning. 3D printing allows clinicians to 
plan more difficult procedures by utilizing 3D-printed models of the anatomy or of existing 
surgical hardware previously implanted (Figure 3). These models allow the clinician to plan the 
surgery to mitigate and account for potential difficulties during the procedure (Lah & Patralekh, 
2018). This planning utilizes advanced 3D spatial and computerized planning software (Figure 4), 
which allows the clinician to account for anatomical differences and product specifications. The 
software results are then programmed into the 3D printer to print the resultant model, which is 
used pre-operatively and intra-operatively for surgical planning. 
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Figure 3 3D Printed Surgical Spine Model 
  
Source: 3D Systems 
 
 
Figure 4 3D Systems VSP Planning Software 
Source: 3D Systems 
Additional beneficial clinical uses of 3DP include the creation of cutting guides, 
customized, patient-specific implants and standardized implants, which assist the surgeon in 
providing clinical options to patients to help improve procedural work-flow, and patient fit and 
clinical outcomes (Mobbs et al., 2017; Wang et al., 2016; Wilcox et al., 2017). 3DP has benefitted 
multiple specialties and continually proves to have beneficial future capabilities concerning the 
3D printing of tools, different biomaterials such as ceramics or Polyetheretherketone (PEEK) 
(Honigmann, 2018), bioprinting of bone and cartilage (Brown, 2017; Lal & Pratralekh, 2018; Yan 
et al., 2018), and the biological printing of organs (Yan et al., 2018). Although there are plentiful 
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clinical uses of 3DP (Ventola, 2014), this research investigates the surgeon adoption of 3DP in 
spinal implants. 
I.4 3D Printed Implants: Spine Application 
Various materials are used to make implants in spine surgeries, including screws, interbody 
spacers, vertebral body replacement, and rods. The most commonly utilized materials to make 
interbody implants are titanium and PEEK, which are both used to restore disc height between 
vertebral bodies while alleviating nerve impingement and reducing spinal instability (Iorio, Reid 
& Kim, 2016). Fusion is desired since it creates further rigidity in the spine to assist the patient in 
recovery.  
There are inherent advantages and disadvantages to both materials (Seaman et al., 2017). 
Titanium has positive biocompatibility that allows osteoinduction and osseointegration of adjacent 
bony structures (Raines et al., 2010). As described by Albrektsson and Johansson (2001), 
osteoinduction is the process by which bone grows on a surface and osseointegration is the stable 
fixation of an implant via direct bone-to-implant contact. The negative aspect of titanium is that it 
is often challenging to determine fusion using radiographic imaging. The mass of solid titanium 
often causes magnetic resonance imaging (MRI) scatter, which complicates the recognition of 
nearby bony anatomy (Ernstberger, Buchhorn & Heidrich, 2009).  
PEEK has positive radiographic imaging due to its translucence, and thus a surgeon can 
identify the potential fusion since they can see through the implant. PEEK may promote fusion 
when coupled with appropriate bone grafting material; however, fusion onto the PEEK material 
may not be possible due to the hydrophobic nature of PEEK (Phan et al., 2016). Fusion onto the 
material helps promote osseointegration; however, PEEK is also expensive to manufacture due to 
the raw materials. There have been attempts to design large windows into titanium interbodies or 
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vertebral body replacement cages. Still, cages can use a limited number of openings before 
compromising the implant’s structural integrity. Companies are marketing titanium-coated PEEK 
devices to help promote bony ingrowth onto the implant. However, due to minimal spacing 
between the vertebral bodies, PEEK coated with titanium often shed upon implantation, effectively 
losing their fusion enhancements (Torstrick et al., 2018). 
3DP (additive manufacturing) affords many advantages compared to prior options. For 
example, a titanium implant can be created with porosity throughout the entire implant rather than 
solely the center of the implant (Figure 5).  
 
 
Figure 5 Stryker Spine 3D Printed Implants 
Source: Stryker Spine 
 
The implant walls can be porous, which helps promote bony fusion in and through the implant. 
Titanium also has a strong affinity to bone, and thus 3D-printed surfaces are often rough and 
promote the necessary bony surface adhesion properties required for fusion (McGilvray et al., 
2018). Also, 3D-printed implants with porosity have more favorable radiographic imaging 
qualities that allow a surgeon to assess the fusion across the implant (Furlow, 2017). The 3DP 
process now allows for more complicated and customized designs (Figure 6) to be created cost-
10 
 
effectively compared to traditional machining or extrusion techniques. From a manufacturing 
perspective, it is more cost-effective to develop implants via additive manufacturing (Garg & 
Mehta, 2018). From a clinical perspective, fusion rates could be improved compared to traditional 
solid titanium or PEEK implants (Kim et al., 2017). There are unfortunately few long-term clinical 
studies that validate these claims (Wilcox et al., 2017), and such studies over time will further 
examine the potential impact of 3DP implants on spinal surgery. 
 
Figure 6 Customized Cervical Implant 
Source: https://www.foxnews.com/health/first-ever-3d-printed-vertebra-implanted-in-12-year-old-cancer-patients-spine 
 
This research attempts to show what intrinsically motivates spine surgeon adoption of 3DP 
technology and to determine whether there are correlations between social norms, clinical 
variables, and surgeon or hospital factors with the adoption of this technology. This research can 
provide sales and marketing departments of medical device organizations with a template of why 
adoption occurs as opposed to intuitive conjecture.  
The research findings could influence how medical device organizations market new 
technology, and the results should provide new insights into how and whom to commercialize 
these technologies in the spine sector of the medical device industry. The same correlations could 
also be applied to all surgeons within the medical device industry to influence marketing activities. 
11 
 
Another practical use of this research regards further refining customer segment targeting when 
launching new technology, as marketing firms can utilize this research to target surgeon profiles 
that are shown by the research to be more open to technology adoption. 
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II CHAPTER 2: LITERATURE REVIEW 
A plethora of research has investigated the adoption of technologies, creating numerous 
theories and frameworks such as the diffusion of innovations theory (Rogers, 2003). This theory 
examines how communication is shared among individuals and organizations that lead to adopting 
technology over time. This has resulted in a widely utilized framework called the adoption curve 
(Figure 7), which classifies adopters into numerous categories such as innovators, early adopters, 
early majority, late majority, and laggards. The adoption curve is highly utilized in the medical 
device industry to categorize surgeon customers during customer segmentation exercises and 
serves as a quick method of segmenting surgeon adopters and helps identify marketing tactics to 
influence subsequent sales. This segmentation unfortunately never identifies the foundational 
behavior regarding why a surgeon adopts technology or not. There are consequently numerous 
other theories, such as the social network theory (Mitchell, 1969) or absorptive capacity theory 
(Cohen & Levinthal, 1990), which analyze adoption influences from a social network or corporate 
standpoint (Wisdom et al., 2014). Previous research has highlighted the strong impact of one’s 
social network on their subsequent adoption of innovation (Chor et al., 2015). For this research, 
the focus is on individuals’ behavioral influences that ultimately drive their behavioral intentions. 
Two historical theories that studied these phenomena are the theory of reasoned action (Fishbein 
& Ajzen, 1975) and the theory of planned behavior (Ajzen, 1985).  
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Figure 7 Roger’s Adoption Curve 
Source: www.crazyegg.com 
 
II.1 Theory of Reasoned Action 
This research investigates surgeon behavior concerning technology adoption, and its 
underlying theoretical influence by the theory of reasoned action (TRA) developed by Fishbein 
and Ajzen (Fishbein & Ajzen, 1975; 1980). The TRA seeks to explain how behavior is determined 
by the behavioral intent to emit the behavior. As depicted in Figure 8, the behavioral intention is 
influenced by attitudinal factors (one’s attitude toward a behavior) and subjective norms (one’s 
perceptions of what they think a group thinks they should do). This theory has been used to predict 
moral behavior. It assumes that one will behave sensibly, given that available knowledge inputs 
have been considered and influence their actions. The more favorable one’s attitude and the 
influence of subjective norms, the higher the perceived control, and thus the more significant the 
intention to enact the behavior. This theory did not account for skills or resources that could impact 
the preferred behavior.  
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Figure 8 Theory of Reasoned Action Model 
Source: Fishbein & Ajzen (1975) 
 
II.2 Theory of Planned Behavior 
In 1985, Ajzen sought to explain the TRA further and created the theory of planned 
behavior (TPB), which is a theoretical model to predict and explain human social behavior and 
serves as a framework for behavioral change interactions (Figure 9). He wanted to establish a 
methodology to measure the influence of behaviors and norms on intention and, ultimately, the 
resultant behavior. He noted that perceived behavioral control was not accounted for in the TRA, 
and thus the TPB would improve upon the TRA by measuring this construct. Perceived behavioral 
control describes one’s behavior as being influenced by their self-confidence (Bandura, Adams, 
Hardy & Howells, 1980). Although the TPB attempts to measure normative influences, it does not 
account for environmental or economic influences, which could ultimately impact one’s 
behavioral intentions (Abbas et al., 2018). This gap is also reflected in the technology acceptance 
model (TAM), which is rooted in the foundation of the TPB. 
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The TPB serves as the foundational theory for this study since the intent is to measure 
behaviors and norms to establish a correlation with surgeon adoption of technology. As a result, it 
was determined that the TAM, which is a model framework based on the TPB, would be needed 
to analyze surgeon adoption behaviors.  
 
 
Figure 9 Theory of Planned Behavior Model 
Source: Ajzen (1991) 
 
II.3 Technology Acceptance Model 
The TAM (Davis, 1989) was developed to guide research on technology adoption as a 
result of human behavioral elements (Davis, 1989). The TAM (Figure 10) was initially designed 
to explore the acceptability of an information system as well as how user behavior affects the 
adoption of information technology (IT) systems. It was created to be more specific than TRA 
which was more general in its analysis of behaviors (Davis, Bagozzi and Warshaw, 1989) The 
model was designed to fulfill three objectives. The first objective was to determine the significant 
variables that mediate between system characteristics and the actual use of computer-based 
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systems by end-users in organizations. The second objective was to determine how these variables 
causally relate to one another, to system characteristics and user behavior. The third and final 
objective was to determine how user motivation can be measured before organizational 
implementation to evaluate the likelihood of user acceptance of the new system. The TAM 
measures these behaviors by using constructs that reflect one’s perceived usefulness (PU) and 
perceived ease of use (PEOU) of the technology. These two constructs then influence users’ 
attitude towards technology (AT), which ultimately influences the user’s behavioral intention (BI) 
to use the technology. It should be noted that subsequent research has also referred to BI as 
intention to use (IU). From BI, there should be some level of adoption of the technology.  
 
 
Figure 10 TAM Framework Model 
Source: Davis, Bagozzi & Warshaw (1989) 
 
The TAM has proven to be a validated framework for studying technology adoption across 
different areas, from consumer adoption to education to hospital management systems (Ratten, 
2015; Nagy, 2018; Escobar-Rodriguez, 2012). In subsequent years since its inception, there have 
been many updates to the TAM. These updates are the final version of TAM by Venkatesh and 
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Davis (1996); the TAM2 by Venkatesh and Davis (2000); the unified theory of acceptance and use 
of technology (UTAUT) by Venkatesh, et al. (2003); and the TAM3 by Venkatesh and Bala 
(2008). Lai (2017) discussed these models and their respective contributions to studying 
technology adoption, specifically to IT. Minimal research has explored the various TAM 
frameworks when considering surgeon adoption of technology for clinical practices. In the few 
studies focused on healthcare, the TAM was limited to studies of electronic health records system 
adoption (Terrizzi, et al. 2012) and automated medication management systems in hospitals 
(Escobar-Rodríguez, Monge-Lozano & Romero-Alonso, 2012; Alemida, Farias & Carvalho, 
2017). The lack of TAM framework application to clinical adoption marks a gap in the body of 
knowledge in this area. The majority of the TAM’s healthcare applications have been towards 
healthcare IT and healthcare mobile technology adoption (Barker et al., 2003; Chang et al., 2003; 
Chau & Hu, 2001; Chen et al., 2007; Duyck et al., 2008; Holden & Karsh, 2010; Hu et al., 1999; 
Liang et al., 2003; Liu & Ma, 2005; Pare et al., 2006; Rawstorne et al., 2000; Schaper & Pervan, 
2007; Tung et al., 2008; Wu et al., 2007; Yi et al., 2006). In addition, as noted with the TPB, the 
TAM does not account for additional environmental or economic factors.  
 
II.4 Technology Acceptance Model 2 
The TAM2 (Venkatesh & Davis, 2000) framework (Figure 11) is utilized in this study to 
help determine which factors influence surgeon adoption of technology for clinical usage. The 
Venkatesh model established new constructs encompassing social influence (subjective norms, 
voluntariness, and image) and cognitive instrumental processes (job relevance, output quality, 
result demonstrability, and perceived ease of use) as determinants of perceived usefulness and 
usage intentions. Based on the other TAM frameworks, this framework is closely aligned with the 
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processes observed in surgeon decision-making when evaluating technology for clinical use based 
on the cognitive instrumental and social influence processes. For this study, the TAM2is applied 
to surgeon adoption; however, this model requires modification to reflect the gap of healthcare-
related factors that may influence the model. This gap is discussed in detail in the theoretical 
framework section. 
 
 
Figure 11 TAM2 Framework Model 
Source: Venkatesh & Davis (2000) 
II.5 Theoretical Importance 
This research investigates factors that influence surgeon adoption of technology in the 
spine industry. These factors are measured using the TAM2, which was modified to examine 
potential moderation from additional external variables, which are critical to the surgeon decision 
process concerning technology adoption. Two authors had different approaches to applying the 
TAM2. The first study examined the use of TAM2 and its applicability to pediatricians and their 
adoption of internet-based health applications (Chismar & Wiley-Patton, 2003). The second author 
published an article that postulated the potential use of TAM to enhance infusion pump use in 
healthcare (Strudwick, 2015). This application was the closest of any of the TAM models 
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concerning clinical adoption intentions. This study further builds upon applying the TAM2 in the 
healthcare setting regarding the clinical adoption of technology used in surgery. Thereby adding 
to the body of knowledge since the majority of healthcare research employing the TAM has been 
focused on healthcare-related IT rather than on different modes of technology such as surgical 
products (e.g., 3D-printed implants). The results of this research could also assist in drafting 
marketing strategies that organizations can use better to influence surgeon adoption of their newly 
designed technology products. 
This research includes both theoretical and practitioner importance. The framework 
developed by Venkatesh and Davis (2000) forms the foundation of this research in examining the 
external factors that influence surgeon adoption of technology, specifically spinal surgeons’ 
adoption of 3D-printed implants. It is theoretically relevant to test the TAM2 frameworks of 
Venkatesh and Davis (2000) within the surgical domain to determine further whether the TAM2 
can be applied to clinical settings rather than solely the historical IT setting. This research will also 
advance the understanding of how external factors can impact surgeons’ behavioral intentions 
concerning technology adoption. This empirical study will help to contribute to the body of TAM 
knowledge by answering the research question: What factors influence the surgical adoption of 
emerging technology in the medical device industry? 
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III CHAPTER 3: RESEARCH DESIGN 
III.1 Introduction 
 This research is based on quantitative research methods that involve surveying 
neurosurgery and orthopedic spine surgeons via a survey instrument created in Qualtrics. The data 
collected by the survey instrument were analyzed to quantitatively determine correlations among 
the constructs established in the TAM2 model. The construct scales were structured on a five-point 
Likert scale. Quantifying external factors of surgeons were studied to determine correlations 
between these factors and subsequent surgeon adoption of 3D-printed technology as measured by 
the TAM2. This research expands upon previous research utilizing the TAM2 by adjusting for 
more relevant clinical and hospital factors that would affect surgeons’ clinical adoption of surgical 
devices. 
 
III.2 Theoretical Framework 
The TAM2 represents the most robust model to utilize as a framework regarding its 
applicability to surgeon technology adoption. Surgeons’ decision-making is often influenced by 
whom they trained, where they trained, and their impressionability by key opinion leaders 
concerning changing surgical techniques and technologies used in their procedures. These social 
interactions primarily determine how surgeons evaluate new technologies and procedures. The 
TAM2 addresses social interaction and its influence on adoption via social influence (subjective 
norms, image, experience, and voluntariness) and cognitive instrumental processes (job relevance, 
output quality, and result demonstrability).  This is executed by measuring surgeons’ perceptions 
of job effectiveness outputs when using the technology. These social and cognitive processes 
influence the overall TAM constructs of PU, PEOU, and IU. 
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Subjective norms, as discussed by Fishbein and Ajzen (1975), measure one’s perception 
that most people who are important to him/her think that he/she should or should not perform the 
behavior in question. Surgeons are influenced by those who train them during residency or 
fellowship. Surgeons attend medical conferences to share and learn the latest surgical techniques 
and use of technologies to improve their clinical outcomes (Escarce, 1996), which often involves 
discussing the surgical outcomes that result from various techniques and technologies. Surgeons 
value the influence of key opinion leaders in the medical device industry (Gagliardi et al., 2017).  
Moore and Benbasat (1991) researched image and defined it as the degree to which the use 
of an innovation is perceived to enhance one's image or status in one's social system. Surgeons 
may have the same image perceptions, as some want to be the first to develop or use new 
technology and want to subsequently teach on the lecture circuit regarding their technology usage 
and how it affects their clinical outcomes. However, many surgeons anecdotally state that they 
utilize technologies not because it makes them look favorable, but because it improves their 
surgical outcomes and ultimately positively impacts their patients. 
Voluntariness measures the extent to which the potential adopters perceive the adoption 
decision to be non-mandatory, as described by Venkatesh and Davis (2000). Surgeons may feel 
that if surgeons in their hospital or regional locale have adopted certain technologies, then they 
must adopt them as well to remain competitive; otherwise, patients may seek other surgeons who 
utilize the technology.  
As defined by Venkatesh and Davis (2000), job relevance concerns an individual’s 
perception regarding the degree to which the target system applies to their job. Surgeons evaluate 
technologies that apply to the surgical procedures that they perform, and those surgeons are rarely 
exposed to technologies that they do not utilize outside of their domain of expertise. 
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Output quality was defined by Davis, Bagozzi, and Warshaw (1992) as to how well the 
system performs the tasks related to their job relevance. This variable closely matches a surgical 
variable called clinical efficacy, which measures how well a treatment or technology succeeds in 
achieving its goal of addressing the problem. The end-user often expects high-quality output, and 
thus the technology must allow the surgeon to perform a task with reproducibility and minimal 
errors. This variable also ties into clinical outcomes or post-operative patient results. Surgeons 
expect utilized technology to improve their clinical outcomes, and if it does not improve workflow, 
efficacy, or outcomes, they may cease using it altogether. 
Result demonstrability was also defined by Moore and Benbasat (1991) as the tangibility 
of the results, of using the technology. This denotes the surgeon’s ability to understand the results 
provided by utilized technology and their ability to communicate this understanding to others. 
The experience variable was studied by Venkatesh and Davis (2000), who concluded that 
social norms become lessened with increased system experience. This construct is not directly 
measured, and thus loyalty will serve in its place as a new variable added to the model and will be 
analyzed to determine any effect on subjective norms and intention to use. Loyalty was determined 
to align with the surgeon and subsequent sales representative and not necessarily with the hospital 
(Burns et al., 2009). The loyalty that a surgeon often develops for a sales representative or vendor 
can be correlated to the surgeon favoring their provided service (Burns et al., 2018). 
The constructs of PU, PEOU, and IU are critical components of the TAM. This study will 
utilize construct scale items from research completed by Venkatesh and Davis (2000) as well as 
Porter and Donthu (2006). The TAM2 differs from the TAM in that TAM2’s external variables 
directly measure the PU rather than the PEOU. As stated by Venkatesh and Davis (2000), extensive 
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empirical evidence shows that the PEOU is significantly linked to intention via its impact on 
perceived usefulness. 
Hospital factors represent a new construct that must be measured to determine whether it 
has a moderating effect on the TAM2 model. Surgeons may have strong tendencies to adopt 
technology, but other factors that the surgeon cannot control include the hospital’s impact on the 
decision-making of surgeons’ technology usage (Gelijns & Rosenberg, 1994). Hospital systems 
attempt to control cost by evaluating the financial implications of new technologies through the 
use of value analysis committees. Unfortunately, there could be uncertainty in the sustainability, 
financially, and clinically, of the technology (Lettieri, 2009). Organizational characteristics or 
inputs thus impact adoption rates (Hikmet et al., 2008). This study’s construct scale was adapted 
from Burns et al. (2009).  
The final variable (dependent variable) regards the surgeon adoption of 3DP implant 
technology, in which the questions ask whether the surgeon adopted technology or not. The 
selection of adoption will equate to one, and the non-adoption of the technology will equate to 
zero. 
The proposed framework (Figure 12) will be called TAM2-Clinical (TAM2-C). This 
research should provide insights into which of the constructs influence surgeon adoption of 
technology, which could highlight a new addition to the body of knowledge of TAM frameworks 
but from a clinician’s viewpoint. For practitioners, this research could provide insights to firms 
developing new technologies regarding how to more precisely target their marketing efforts 
towards surgeons in the spine industry. This would also be applicable to other sectors in the 
medical device industry since they are all bound by the same constructs, as highlighted in the 
theoretical framework.  
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Figure 12 Proposed TAM2-C Framework Model 
 
III.3 Research Questions and Hypothesis Testing 
 
Research Question: 
What factors influence the surgeon adoption of emerging technology in the spinal medical device 
industry? 
 
Hypotheses and Rationale 
 TAM constructs such as PU, PEOU, and IU have been thoroughly investigated and shown 
to influence adoption positively. Although the TAM has been significantly studied in IT 
applications over the past 30 years, there has been limited research into its use in healthcare 
surgical applications. Regarding surgeons and their influences on 3D-printed implant adoption, the 
PU, PEOU, and IU are expected to have positive relationships similar to those observed in IT. This 
implies that the use of the TAM will apply to surgical technology beyond IT technology adoption. 
H1: Surgeons’ perceived usefulness positively influences the intention to use. 
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H2: Surgeons’ perceived ease of use positively influences the intention to use. 
H3: Surgeons’ perceived ease of use positively influences perceived usefulness. 
 
Subjective norms, as discussed by Fishbein and Ajzen (1975), measures one’s perception 
that most people who are important to him/her think that he/she should or should not perform the 
behavior in question. Surgeons are influenced by their former proctors, influential key opinion 
leaders, and colleagues within their social and medical network. Surgeons will investigate what 
technologies others are using and measuring those surgeon’s clinical success. These influences 
will impact how a surgeon views the adoptability of specific devices.  
H4: Surgeons’ subjective norms positively influence perceived usefulness. 
H5: Surgeons’ subjective norms positively influence intention to use. 
 
Moore and Benbasat (1991) researched image and defined it as the degree to which the use 
of an innovation is perceived to enhance one's perception or status in one's social system. Users of 
innovations in the medical field are sometimes viewed favorably by others. Especially if their 
usage provides demonstrable improved clinical outcomes.  Those individuals will become more 
visible as a result of discussing their clinical outcomes and technology usage in public forums. 
Thus, potentially enhancing their image among their social and medical networks.  
H6: Surgeons’ image positively influences perceived usefulness. 
 
As defined by Venkatesh and Davis (2000), job relevance concerns an individual’s 
perception regarding the degree to which the target system applies to their job. Surgeons will adopt 
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technologies that provide them with clinical and procedural work-flow benefits. Surgeons choose 
technologies that, in general, will improve or enhance their surgical skill set. 
H7: Surgeons’ job relevance positively influences perceived usefulness. 
 
Output quality was defined by Davis, Bagozzi, and Warshaw (1992) as to how well the 
system performs the tasks related to their job relevance. The technology should demonstrate 
outputs that are reproducible, measurable, and improves one’s margin of error in the procedure. 
Surgeons will favor technology that improves the clinical outcomes for their patients and 
establishes improved clinical efficacy. If a technology does not demonstrate improved output 
quality, it’s perceived usefulness will diminish.  
H8: Surgeons’ output quality positively influences perceived usefulness. 
 
Result demonstrability was also defined by Moore and Benbasat (1991) as the tangibility 
of the results of using the technology. The surgeon must be able to understand the results provided 
by the technology and be able to communicate this understanding to others. If the surgeon 
perceives the technology to be useful, they should be able to communicate this result to others. 
This is important when surgeons must explain the benefits of the technology to decision-makers 
within the hospital to determine if the system will be approved for use by value analysis 
committees. 
H9: Surgeons’ result demonstrability positively influences perceived usefulness. 
 
 Prior research discussed in the literature review has shown that once a subject’s behavioral 
intent to use IT technology has been established by PU and PEOU, the adoption of the technology 
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more readily occurs. The same assumption can apply to surgeons’ intention to use surgical 
technology clinically.  
H10: Intention to use positively influences surgeon adoption of technology. 
 
Loyalty represents a new variable added to the model to measure surgeons’ corporate 
loyalty. The surgeon’s relationship with a medical device organization or local sales representative 
may influence their perception of the technology’s usefulness. Research has shown that loyalty is 
established by surgeons and local sales representatives based on service, training, and perceived 
trust (Burns et al., 2018, 2019; O’Connor et al., 2016). There is also interestingly supplemental 
evidence implying that loyalty is not established due to a lack of trust by the surgeon and sales 
representative (Gagliardi et al., 2017), which results in the following: 
H11: Surgeons’ loyalty moderates the relationship between subjective norms and 
perceived usefulness. 
H12: Surgeons’ loyalty moderates the relationship between subjective norms and 
intention to use. 
 
Voluntariness measures the extent to which the potential adopters perceive the adoption 
decision to be non-mandatory, as described by Venkatesh and Davis (2000). Surgeons may believe 
they have no choice in adopting the technology for a potential number of reasons. In essence, 
hospital decision-makers have mandated it, well-informed patients may request it or go to another 
surgeon who does use the technology or their social and medical network all utilize the technology; 
thus they must adopt to minimize the perception that they are not providing the best therapeutic 
options for their patients.  
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H13: Voluntariness moderates the relationship between subjective norms and 
intention to use. 
 
Hospital factors represent a new variable that will be measured to determine whether it has 
a moderating effect on the TAM2 model. While a surgeon may have intentions to adopt a 
technology, they do not purchase the technology. This is done by the hospital in which the surgeon 
is technically an employee. Thus, the hospital has control over the purchase of goods used in the 
facility. Hospital influence impacts technology adoption due to the hospital’s need for improved 
clinical outcomes and hospital efficiencies (Gelijns & Halm, 1991). These decision criteria 
potentially mitigate surgeons’ loyalty bias that may exist regarding the technology (O’Connor et 
al., 2016; Burns et al., 2016, 2018).  
H14: Hospital factors moderate the relationship between intention to use and 
adoption of technology. 
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IV CHAPTER 4: METHODOLOGY 
IV.1 Data Collection and Sampling 
This research examines the factors that influence surgeon adoption of emerging technology 
in the medical device industry, more specifically, spinal surgeons’ adoption of 3DP implants. 
Primary data collection was performed via a survey instrument, and the survey was created using 
the Qualtrics survey system. Although there are 6,524 spine surgeons globally (Falavigna, 2018), 
I utilized an email list server compiled from various surgeon conferences and an email list 
compiled by Stryker Spine Corporation, and the resulting list accounted for approximately 2,500 
surgeons globally. I targeted a survey completion target of n = 300, which would equate to a 12% 
response rate. Surgeons were targeted via numerous methods: The first option was via the 
compiled email list server, where emails linking to the survey and inviting surgeons to complete it 
were distributed three times over three months. The second option was via surgeon visits to the 
Stryker Spine corporate office, where surgeons were invited to complete the survey at their leisure 
and were given a business card with the survey link information, including the addition of a quick 
response (QR) code. The third recruitment option concerned individual networking via LinkedIn 
connections, where surgeon contacts were emailed an invitation to complete the survey via 
LinkedIn messaging. A fourth recruitment activity involved surgeon participants at various 
surgeon conferences held in the United States, who were given the survey instrument business card 
as well. Finally, the fifth option was via assistance from select sales representatives who 
encouraged surgeon customers to complete the survey by visiting the survey link provided via 
email. All surgeons contacted via office visits, LinkedIn, or sales representative interaction were 
cross-referenced with the original surgeon email list. The final results consisted of 100 completed 
surveys out of 2,500 surgeons, representing an effective response rate of 4%. The participant 
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strategy allowed the researcher to obtain responses from a variety of spinal surgeons. They were 
selected based on the following criteria: orthopedic or neurosurgeons operating weekly. 
Participants were provided the option to access the survey twenty-four hours per day and advised 
to complete the survey during non-business hours. Once the data were retrieved from the internet 
survey tool, it was entered into SPSS for analysis and reporting.  
 
IV.2 Measures 
The scales for the various theoretical constructs (subjective norms, image, job relevance, 
output quality, result demonstrability, experience, voluntariness, PU, PEOU, and IU) were utilized 
from previously established studies. The TAM scales of PU, PEOU, and IU are to be measured 
using items adapted from Davis (1989) and Davis et al. (1989). The measurements of subjective 
norms were adapted from Taylor and Todd (1995); result demonstrability and image from Moore 
and Benbasat (1991); job relevance and output quality from Davis et al. (1992); and hospital factors 
from Burns et al. (2009). However, some items in the hospital scale were adjusted to fit the focus 
and relevance of this study. Finally, loyalty was measured by utilizing a three-item scale that 
addressed corporate contracts, corporate product preferences, and sales representative 
relationships. 
 
The survey instrument questions were further adjusted based on prior research by Chismar 
and Wiley-Patton (2003) as well as Burns, Housman, Booth, and Koenig (2009). These researchers 
made modifications appropriate for their research, and this research performed two similar 
adjustments. Sentences were reworded to incorporate the nomenclature of technology and the word 
surgeon to questions where applicable to increase interest by providing personal and professional 
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appeal and thus enhance the response rate (Chismar & Wiley-Patton, 2003). This research also 
substituted the word “system” with technology. The full list of questions and their associated 
constructs are referenced in Appendix A. The survey was tested by three surgeons to ensure that 
the questions were clear and that the length of the survey was appropriate and maintained surgeon 
engagement. The estimated time required for the survey’s completion was five to ten minutes.  
 
IV.3 Reliability 
Reliability regards the internal consistency of items within the construct and is measured 
via Cronbach’s alpha. According to Venkatesh and Davis (2000), the constructs were determined 
to have internal consistency reliability coefficients greater than 0.70. Table 1 below highlights the 
Cronbach’s alpha coefficient for each scale. Initial testing of the original constructs of results 
demonstrability, loyalty, and hospital factors resulted in lower internal consistency. The results 
demonstrability construct resulted in a Cronbach’s alpha of 0.31. By removing item 4, “I would 
have difficulty explaining why using the technology may or may not be beneficial.”, the resultant 
Cronbach’s alpha was improved to 0.78. The loyalty construct resulted in a Cronbach’s alpha of 
0.24. By removing item 3, “Do you have any corporate teaching and/or development contracts 
within the spine industry?”, the resultant Cronbach’s alpha was improved to 0.52. Finally, the 
hospital factors construct resulted in a Cronbach’s alpha of 0.69. By removing item 4, “I have 
influence on hospital vendor selection.”, the resultant Cronbach’s alpha was improved to 0.74. 
Thus, providing improved internal consistency for each of the three constructs. 
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Table 1 Source of Constructs 
Construct Source Reliability 𝛼 
Perceived Usefulness* 0.87 – 0.98 0.91 
Perceived Ease of Use* 0.86 – 0.98 0.82 
Intention to Use* 0.82 – 0.97 0.92 
Subjective Norm* 0.81 – 0.94 0.85 
Image* 0.80 – 0.93 0.91 
Job Relevance* 0.80 – 0.95 0.86 
Output Quality* 0.82 – 0.98 0.76 
Results Demonstrability* 0.80 – 0.97 0.78 
Voluntariness* 0.82 – 0.91 0.79 
Loyalty NA 0.52 
Hospital Factors** NA 0.74 
*Source: Venkatesh & Davis (2000) 
**Source: Burns et al. (2009) 
 
IV.4 Validity 
 The validity of the constructs was measured by analyzing convergent validity within the 
measures. The resultant correlation coefficients were all significant at the 0.01 and 0.05 level, 
thus confirming validity (refer to Appendix B).  
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IV.5 Data Analysis 
The data analysis process included the coding and cleaning of the data collected from the 
survey. Statistical calculations were then performed via SPSS to analyze the collected data. The 
hypothesized model was examined using regression analysis to test the relationships of the 
constructs.  
Coding  
The survey measurements of the TAM2 used a five-point Likert scale ranging from 
strongly disagree to agree strongly. Each point was assigned a numerical value, which was used to 
record the responses to each survey question. Each question was assigned a variable name, and 
each respondent a unique ID. All of this information was downloaded into SPSS for analysis and 
exported into Excel for Smart-PLS3 analysis.  
Cleaning 
The data from the spreadsheet were loaded into SPSS, and frequencies on all of the 
variables were calculated, and error tests were run. Based on the selected variables, the mean, 
median, mode, and standard deviation were determined. These tasks allowed validating the data 
and eliminating any surveys that were not valid (e.g., missing data or incorrect data entry). As each 
question required an answer before progressing forward in the survey, there were no issues of 
missing data. Text variables were correctly coded to reflect proper measurement. 
Statistical Outputs  
Frequency tests were performed on the cleaned data, which included reviewing the 
descriptive statistics. The technology acceptance factors in the TAM2 were captured on a Likert 
scale (1 to 5), and the overall scores for each factor were calculated by averaging the scores from 
each item. Correlations were performed using Pearson’s correlation to determine whether there 
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was a relationship present between the independent and dependent variables. Also, Spearman’s 
Rho calculations were performed to test the strength of the relationship between the variables. 
Linear regression was performed to address each null hypothesis using the testing procedures 
defined by Pallant (2016). First, the data were screened for outliers as the participants’ residuals 
were standardized, and the resulting z-scores were utilized to identify outliers. The next step was 
to assess model linearity and homoscedasticity using a plot of standardized residuals. Finally, the 
regression coefficients statistics were calculated to determine whether the independent variables 
were significant predictors of the targeted dependent variables (e.g., perceived usefulness). 
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V CHAPTER 5: RESULTS 
V.1 Descriptive Statistics 
 The number of subjects who participated in the study was 100, and the descriptive statistics 
for their demographics are listed in Table 2. Sixty-nine of the surgeon participants were orthopedic 
surgeons, while the remaining 31 were neurosurgeons. The majority of the surgeons were attending 
(97%), while the remaining 3% were residents. There were no fellows. Tenure was reported as 
follows: 0-10 years (38%), 11-20 years (29%), 21-30 years (23%) and 31+ years (10%). Age was 
distributed as follows: 25-34 (6%), 35-44 (33%), 45-54 (28%), 55-64 (27%) and 65+ (6%). 96% 
of the respondents were male, and 4% were female. Finally, 80% of the respondents were from 
various U.S. states, while the remaining 20% were from international countries (6% Australia, 
12% Europe, 1% Middle East, 1% Southeast Asia). 
 The surgeon participants completed the 42-item TAM2-C survey. The descriptive statistics 
for the TAM2-C are listed in Table C1 (see Appendix C). The TAM variables in the TAM2-C 
identified in this research were recorded via a five-point Likert scale. The overall scores for each 
construct were calculated by averaging the scores for each item. In Table 3, the descriptive 
statistics for the traditional TAM variables (PU, PEOU, and IU) of the TAM2-C highlight that PU 
had the highest average value with a mean of 15.55 (SD = 3.21). Of the variables traditionally 
associated with the TAM2 (SN, I, V, JR, OQ, and RD), voluntariness had the highest average value 
with a mean of 12.89 (SD = 2.07).  
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Table 2 Surgeon Demographics 
Variable n 
Specialty  
Ortho 69 
Neuro 31 
  
Clinical Position  
Attending 97 
Fellow 0 
Chief Resident 1 
Resident 2 
  
Tenure  
0-10 38 
11-20 29 
21-30 23 
31+ 10 
  
Age  
25-34 6 
35-44 33 
45-54 28 
55-64 27 
65+ 6 
  
Gender  
Male 96 
Female 4 
  
Geographic Location  
United States 80 
Australia, Victoria 1 
Australia, NSW 4 
Australia, Queensland 1 
Italy 3 
Germany 1 
Ireland 3 
UK 5 
Israel 1 
Thailand 1 
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Table 3 Descriptive Statistics for TAM-C Subscales 
Subscale n Min Max M SD 
Perceived Usefulness 100 4.00 20.00 15.55 3.21 
Perceived Ease of Use 100 4.00 20.00 14.83 3.09 
Intention to Use 100 3.00 10.00 8.01 1.71 
Subjective Norm 100 2.00 10.00 6.20 1.84 
Voluntariness 100 3.00 15.00 12.89 2.07 
Image 100 3.00 15.00 8.41 3.09 
Job Relevance 100 2.00 10.00 8.09 1.64 
Output Quality 100 2.00 10.00 7.32 1.63 
Result Demonstrability 100 6.00 15.00 12.65 1.87 
Loyalty 100 2.00 13.00 7.86 2.21 
Hospital Factors 100 11.00 40.000 27.71 5.33 
 
V.2 Correlation Analysis 
 Correlation analysis was conducted to determine the strength and direction of the linear 
relationship between the variables. Using SPSS, a bivariate calculation was performed to 
determine the direction (Spearman’s Rho correlation) and strength of the relationships (the size of 
the value of the correlation coefficient). Strength is determined by the correlation reflecting either 
0 (no relationship), 1 (positive relationship) or -1 (negative relationship). The results are shown in 
Table 4 below. 
 
Table 4 Correlation Analysis 
Scale PU PEOU IU SN V I JR OQ RD L HF 
PU 1.00           
PEOU 0.48** 1.00          
IU 0.62** 0.57** 1.00         
SN 0.35** 0.21* 0.38** 1.00        
V 0.14 0.12 0.08 0.09 1.00       
I 0.32** 0.11 0.29** 0.29** -0.01 1.00      
JR 0.51** 0.33** 0.54** 0.38** 0.12 0.14 1.00     
OQ 0.46** 0.47** 0.53** 0.28** 0.05 0.30** 0.45** 1.00    
RD 0.46** 0.38** 0.43** 0.22* 0.38** 0.26* 0.50** 0.44** 1.00   
L 0.14 0.37** 0.17 0.16 0.10 0.15 0.06 0.12 0.25* 1.00  
HF -0.07 -0.02 -0.00 0.05 0.06 0.14 0.05 0.08 0.06 0.16 1.00 
**Correlation is significant at the 0.01 level (2-tailed) 
*Correlation is significant at the 0.05 level (2-tailed) 
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V.3 Multicollinearity 
 Multicollinearity was tested to ensure that there was no overlapping of factors among the 
independent variables. The tolerance and variance inflation factor (VIF) were used to measure 
collinearity. Tolerance measures the amount of variability of the independent variable not being 
explained by the other variables in the model, while the VIF is the inverse of tolerance. “If the 
Tolerance is small (less than 0.10), then the multiple correlations are high among the variables, 
thus implicating there is multicollinearity. If collinearity is present among the variables by having 
VIF values greater than 10, then those variables would be removed" (Pallant, 2016, p. 159). The 
resultant tolerance values were all much higher than 0.10, while the VIF values were below 2.0, 
as represented below in Table 5.  
 
Table 5 Multicollinearity 
Factor Tolerance VIF 
Subjective Norm 
Image 
Job Relevance 
Output Quality 
Result Demonstrability 
Loyalty 
Voluntariness 
0.77 1.30 
0.79 1.26 
0.64 1.57 
0.60 1.66 
0.70 1.43 
0.99 1.01 
0.99 1.01 
Perceived Usefulness 0.70 1.44 
Perceived Ease of Use 0.71 1.41 
Intention to Use 0.99 1.00 
Hospital Factors 0.99 1.00 
 
 
V.4 Regression Model Analysis 
 This research model is complicated due to the number of variables. Due to the n of 100 and 
eleven different variables, the power of the model is potentially compromised. The sampling 
should have been closer to 280. The analysis thus involved examining the linear regression effect 
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of each of the model pathways via SPSS, which involved analyzing the independent variables’ 
(IV) interaction with the dependent variables (DV). The first analysis involved analyzing the 
model effect on the independent variable of perceived usefulness, and the regression coefficients 
were calculated to determine whether the variable was a significant predictor for the said variable. 
 The first run involved testing the independent variables, subjective norms, image, job 
relevance, output quality, and results demonstrability for the dependent variable of perceived 
usefulness. The results are shown below in Tables 6 – 8: 
 
Table 6 Perceived Usefulness Model Summary 
Model R R2 Adjusted R2 
Std. Error of 
the Estimate 
1 0.53a 0.28 0.24 2.79 
a. Predictors: (Constant), Image, JR, SN, RD, OQ 
 
 
Table 7 Perceived Usefulness ANOVA 
Model 
Sum of 
Squares df Mean Square F p 
1 Regression 285.60 5.00 57.12 7.32 .00a 
Residual 733.15 94.00 7.80   
Total 1018.75 99.00    
Dependent Variable: PU 
a. Predictors: (Constant), Image, JR, SN, RD, OQ 
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Table 8 Perceived Usefulness Coefficients 
Model 
  
t p B SE Beta 
1 (Constant) 4.51 2.07 - 2.18 0.03 
SN 0.29 0.17 0.17 1.69 0.10 
JR 0.38 0.21 0.19 1.78 0.08 
OQ 0.38 0.21 0.19 1.83 0.07 
RD 0.22 0.18 0.13 1.26 0.21 
I 0.06 0.10 0.06 0.64 0.52 
Dependent Variable: PU 
 
 Upon further analysis, it was determined that by removing the two variables with the largest 
non-significance (result demonstrability and image), the model became much more statistically 
significant, as demonstrated below in Tables 9 – 11:  
 
Table 9 Perceived Usefulness Model Summary w/o RD & I 
Model R R2 Adjusted R2 
Std. Error of 
the Estimate 
1 0.51a 0.26 0.24 2.80 
a. Predictors: (Constant), Output Quality, SN, JR 
 
Table 10 Perceived Usefulness ANOVA w/o RD & I 
Model 
Sum of 
Squares df Mean Square F p 
1 Regression 267.16 3.00 89.06 11.38 .00a 
Residual 751.59 96.00 7.83   
Total 1018.75 99.00    
Dependent Variable: PU 
a. Predictors: (Constant), OQ, SN, JR 
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Table 11 Perceived Usefulness Coefficients w/o RD & I 
Independent Variable b SE Beta t p 
 (Constant) 6.36 1.61  3.95 0.00 
SN 0.34 0.17 0.19 2.04 0.04 
JR 0.45 0.20 0.23 2.20 0.03 
OQ 0.48 0.20 0.24 2.39 0.02 
Dependent Variable: PU 
  
Subjective norms, job relevance, and output quality were the only independent variables 
with p values lower than 0.05 and an adjusted R2 of 0.24, thus having an effect on perceived 
usefulness. Image and results demonstrability demonstrated p values higher than 0.05, thus having 
no impact on perceived usefulness. By removing image and result demonstrability, the adjusted 
R2 did not change, thus highlighting that these two predictors did not reliably contribute to PU. 
 
The second analysis involved testing the relationship of PEOU on PU via linear regression. 
The results are shown below in Tables 12 – 14: 
 
Table 12 PEOU & PU Model Summary 
Model R R2 Adjusted R2 
Std. Error of 
the Estimate 
1 0.47a 0.22 0.21 2.84 
a. Predictors: (Constant), PU 
  
 
Table 13 PEOU & PU ANOVA 
Model 
Sum of 
Squares df Mean Square F p 
1 Regression 228.39 1.00 228.39 28.32 .00a 
Residual 790.37 98.00 8.07   
Total 1018.75 99.00    
Dependent Variable: PU 
a. Predictors: (Constant), PEOU 
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Table 14 PEOU & PU Coefficients 
Model 
  
t p B SE Beta 
1 (Constant) 8.26 1.40 - 5.90 0.00 
PEOU 0.49 0.09 0.47 5.32 0.00 
Dependent Variable: PU 
 
PEOU has a p-value lower than 0.05 and an adjusted R2 of 0.21, thus having an effect on 
perceived usefulness and contributing 21% of the variance for PU. 
The third analysis executed the linear regression model on the remaining TAM variables, 
which involves analyzing the SN, PU, and PEOU effects on IU. These results are shown below in 
Tables 15 - 17: 
Table 15 Intention to Use Model Summary 
Model R R2 Adjusted R2 
Std. Error of 
the Estimate 
1 0.70a 0.49 0.47 1.24 
a. Predictors: (Constant), PEOU, SN, PU 
  
 
Table 16 Intention to Use ANOVA 
 
Model 
Sum of 
Squares df Mean Square F p 
1 Regression 140.81 3.00 46.94 30.41 .00a 
Residual 148.18 96.00 1.54   
Total 288.99 99.00    
Dependent Variable: IU 
a. Predictors: (Constant), PEOU, SN, PU 
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Table 17 Intention to Use Coefficients 
Model 
  
t p B SE Beta 
1 (Constant) 1.08 0.74 - 1.45 0.15 
SN 0.16 0.07 0.18 2.24 0.03 
PU 0.15 0.05 0.28 3.29 0.00 
PEOU 0.24 0.05 0.44 5.23 0.00 
Dependent Variable: IU 
 
SN, PU, and PEOU all have p values lower than 0.05 and an adjusted R2 of 0.47, thus 
having an effect on the intention to use and contributing 47% of the variance for intention to use. 
 Finally, the last regression was run on the relationship between intention to use and 3DP 
implant adoption. The results are presented in Tables 19 – 20. 
 
Table 18 3DP Implant Adoption Model Summary 
Model R R2 Adjusted R2 
Std. Error of 
the Estimate 
1 0.230a 0.05 0.04 0.431 
a. Predictors: (Constant), PEOU, SN, PU 
  
 
Table 19 3DP Implant Adoption ANOVA 
 
Model 
Sum of 
Squares df Mean Square F p 
1 Regression 1.03 1 1.03 5.55 .02a 
Residual 18.21 98 0.19   
Total 19.24 99    
Dependent Variable: 3DP Implant Adoption 
a. Predictors: (Constant), IU 
 
  
44 
 
Table 20 3DP Implant Adoption Coefficients 
Model 
  
t p B SE Beta 
1 (Constant) 0.26 0.21 - 1.26 0.21 
IU 0.06 0.02 0.23 2.35 0.02 
Dependent Variable: 3DP Implant Adoption 
 
Intention to use has a p-value lower than 0.05 and an adjusted R2 of 0.04, thus having an 
effect on perceived usefulness, yet only contributing 4% of the variance for the actual adoption of 
3DP implants. 
The next analysis involved testing the moderator variables loyalty and voluntariness and 
their impact on the model. The analysis was conducted using the Process Analysis v3.4 created by 
Andrew Hayes (Hayes, 2017). This logistic regression path analysis modeling tool allows 
measurement of the effects of meditator and moderator models. The resulting series of logistic 
regression analysis is depicted below in Tables 21 – 23. 
Table 21 Process Analysis of Loyalty on SN & PU 
 
Model Summary of Outcome Variable PU (Y: PU, X: SN, W: L) 
 
R R2 MSE F df1 df2 p 
0.36 0.13 9.26 4.67 3.00 96.0 0.00 
 
Model of Outcome Variable PU 
Variable Coefficient SE t p LLCI ULCI 
Constant 13.42 3.50 3.83 0.00 6.47 20.37 
SN 0.28 0.55 0.50 0.62 -0.82 1.37 
L -0.22 0.47 -0.48 0.63 -1.15 0.70 
SN X L 0.04 0.07 0.61 0.54 -0.09 0.18 
 
Test(s) of highest order unconditional interaction(s) 
 
Variable R2 Change F df1 df2 p 
SN x L 0.00 0.38 1.00 96.0 0.54 
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Table 22 Process Analysis of Loyalty on SN & Intention to Use 
 
Model Summary of Outcome Variable IU (Y: IU, X: SN, W: L) 
 
R R2 MSE F df1 df2 p 
0.40 0.6 2.54 5.94 3.00 96.0 0.00 
 
Model of Outcome Variable IU 
 
Variable Coefficient SE t p LLCI ULCI 
Constant 5.06 1.83 2.76 0.0069 1.42 8.70 
SN 0.34 0.29 1.18 0.24 -0.23 0.91 
L 0.13 0.24 0.51 0.61 -0.36 0.62 
SN X L -0.003 0.04 -0.08 0.94 -0.08 0.07 
 
Test(s) of highest order unconditional interaction(s) 
 
Variable R2 Change F df1 df2 p 
SN x L 0.00 0.01 1.00 96.0 0.94 
 
 
Table 23 Process Analysis of Voluntariness on SN & Intention to Use 
 
Model Summary of Outcome Variable IU (Y: IU, X: SN, W: V) 
 
R R2 MSE F df1 df2 p 
0.38 0.14 2.57 5.44 3.00 96.0 0.00 
 
Model of Outcome Variable IU 
Variable Coefficient SE t p LLCI ULCI 
Constant 7.85 2.29 3.43 0.00 3.31 12.39 
SN 0.05 0.36 0.14 0.89 -0.66 0.76 
V -0.16 0.18 -0.89 0.37 -0.52 0.20 
SN X V 0.02 0.03 0.85 0.39 -0.03 0.08 
 
Test(s) of highest order unconditional interaction(s) 
 
Variable R2 Change F df1 df2 p 
SN x V 0.01 0.73 1.00 96.0 0.39 
 
 
 The p-values are higher than 0.05 for loyalty and voluntariness for the subjective norms 
relationship with intention to use. Also, the p-value of loyalty for the subjective norms relationship 
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with perceived use is higher than 0.05 as well. Thus, loyalty and voluntariness have no moderating 
effect on the model. 
 
 The hospital factors relationship was analyzed to determine whether it had a moderating 
effect on the relationship of intention to use with adoption. Adoption was based on either yes or 
no to the adoption of 3DP implants, and the p-value was lower than 0.05, thus showing a 
moderating effect on the IU to 3DP adoption relationship. The results are presented below in Table 
24. 
 
Table 24 Process Analysis of Hospital Factors on IU & 3DP Adoption 
 
Model Summary of Outcome Variable 3DP Adoption (Y: 3DP Adoption, X: IU, W: HF) 
Variable Coefficient SE z p LLCI ULCI 
Constant 12.78 6.90 1.85 0.06 -0.75 26.30 
IU -1.54 0.84 -1.84 0.06 -3.18 0.10 
HF -0.50 0.24 -2.05 0.04 -0.98 -0.02 
IU X HF 0.07 0.03 2.19 0.03 0.00 0.12 
 
Test(s) of highest order unconditional interaction(s) 
 
Variable Chi2  df p 
IU x HF 5.61 1.00 0.02 
 
V.5 Hypothesis Findings 
H1: Surgeons’ perceived usefulness positively influences the intention to use. 
H2: Surgeons’ perceived ease of use positively influences the intention to use. 
H3: Surgeons’ perceived ease of use positively influences perceived usefulness. 
The TAM constructs were analyzed to determine whether the use of TAM was a valid 
application for measuring surgeons’ clinical adoption of surgical technology (e.g., 3DP implants). 
The standardized coefficients for the TAM constructs were found to be H1: β = 0.28, H2: β = 0.44 
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and H3: β = 0.47. All three hypotheses reported a significance of p < 0.05 and, therefore, were 
supported.  Thus, perceived usefulness and perceived ease of use have positive relationships with 
the intention to use, while perceived ease of use has a positive relationship with perceived 
usefulness.  
 
H4: Surgeons’ subjective norms positively influence perceived usefulness. 
 The standardized coefficient for subjective norms’ influence on perceived usefulness was 
β = 0.19, p < 0.05. This suggests that the independent variable, subjective norm, has a positive 
influence on perceived usefulness, and thus the hypothesis was supported. 
 
H5: Surgeons’ subjective norms positively influence intention to use. 
The standardized coefficient for subjective norms’ influence on intention to use was β = 
0.18, p < 0.05. This suggests that the independent variable subjective norms has a positive 
influence on intention to use, and thus the hypothesis was supported. 
  
H6: Surgeons’ image positively influences perceived usefulness. 
The standardized coefficient for surgeons’ image on perceived usefulness was β = 0.06, p 
> 0.05. This suggests that the independent variable image does not have a positive influence on 
perceived usefulness, and thus the hypothesis was rejected. 
 
H7: Surgeons’ job relevance positively influences perceived usefulness. 
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The standardized coefficient for subjective norms’ influence on perceived usefulness was 
β = 0.23, p < 0.05. This suggests that the independent variable job relevance has a positive 
influence on perceived usefulness, and thus the hypothesis was supported. 
 
H8: Surgeons’ output quality positively influences perceived usefulness. 
The standardized coefficient for output quality’s influence on perceived usefulness was β 
= 0.24, p < 0.05. This suggests that the independent variable output quality has a positive influence 
on perceived usefulness, and thus the hypothesis was supported. 
 
H9: Surgeons’ result demonstrability positively influences perceived usefulness. 
The standardized coefficient for result demonstrability’s influence on perceived usefulness 
was β = 0.13, p > 0.05. The results suggest that the independent variable result demonstrability 
does not have a positive influence on perceived usefulness, and thus the hypothesis was rejected. 
 
H10: Intention to use positively influences surgeon adoption of technology. 
The standardized coefficient for intention to use’s influence on surgeon adoption of 3DP 
implant technology was β = -1.54, p > 0.05. The results suggest that the intention to use variable 
does not have a positive influence on surgeon adoption, and thus the hypothesis was rejected. 
 
H11: Surgeons’ loyalty moderates the relationship between subjective norms and perceived 
usefulness. 
The standardized coefficient for loyalty’s moderation influence on the relationship between 
subjective norm and perceived usefulness was β = 0.04, p > 0.05. The results suggest that the 
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loyalty variable does not have a moderation effect on the relationship between subjective norms 
and perceived usefulness, and thus the hypothesis was rejected. 
 
H12: Surgeons’ loyalty moderates the relationship between subjective norms and intention to use. 
The standardized coefficient for loyalty’s moderation influence on the relationship between 
subjective norms and intention to use was β = -0.03, p > 0.05. This suggests that the loyalty variable 
does not have a moderation effect on the relationship between subjective norms and intention to 
use, and thus the hypothesis was rejected. 
 
H13: Voluntariness moderates the relationship between subjective norms and intention to use. 
The standardized coefficient for voluntariness’ moderation influence on the relationship 
between subjective norm and intention to use was β = 0.02, p > 0.05. This suggests that the 
voluntariness variable does not have a moderation effect on the relationship between subjective 
norms and intention to use, and thus the hypothesis was rejected. 
 
H14: Hospital factors moderate the relationship between intention to use and adoption of 
technology. 
The standardized coefficient for hospital factors’ moderation influence on the relationship 
between intention to use and surgeon adoption was β = 0.07, p > 0.05. This suggests that the 
hospital factors variable does have a moderation effect, albeit small, on the relationship between 
intention to use and surgeon adoption, and thus the hypothesis was supported. 
The results for the hypotheses findings are represented in Table 5.24 below: 
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Table 25 Hypothesis Support (*p < 0.05) 
Technology Acceptance Model (Validation) β p Supported 
H1 Surgeons’ perceived usefulness positively influences 
intention to use 
0.28 0.00* Y 
H2 Surgeons’ perceived ease of use positively influences 
intention to use 
0.44 0.00* Y 
H3 Surgeons’ perceived ease of use positively influences 
perceived usefulness 
0.47 0.00* Y 
Independent Variables Influences on Model β p Supported 
H4 Surgeons’ subjective norms positively influence 
perceived usefulness 
0.19 0.04* Y 
H5 Surgeons’ subjective norms positively influence 
intention to use 
0.18 0.03* Y 
H6 Surgeons’ image positively influences perceived 
usefulness 
0.06 0.52 N 
H7 Surgeons’ job relevance positively influences 
perceived usefulness 
0.23 0.03* Y 
H8 Surgeons’ output quality positively influences 
perceived usefulness 
0.24 0.02* Y 
H9 Surgeons’ result demonstrability positively influences 
perceived usefulness 
0.13 0.21 N 
H10 Intention to use positively influences surgeon adoption 
of technology 
-1.54 0.06 N 
Moderation Influences on Model β p Supported 
H11 Surgeons’ loyalty moderates the relationship between 
subjective norms and perceived usefulness 
0.04 0.54 N 
H12 Surgeons’ loyalty moderates the relationship between 
subjective norms and intention to use 
0.00 0.94 N 
H13 Voluntariness moderates the relationship between 
subjective norms and intention to use 
0.02 0.39 N 
H14 Hospital factors moderate the relationship between 
intention to use and adoption of technology 
0.07* 0.03 Y 
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After analyzing the results, the initial model framework proposed for this research has been 
further defined to achieve a more straightforward framework for studying surgeons’ behavioral 
intentions towards the clinical adoption of technology. The more simplified, empirically supported 
model is shown below (Figure 13): 
 
 
Figure 13 Empirically Supported TAM2-C Framework Model 
  
The simplified model highlights that SN accounts for 19% of the variance for PU, while job 
relevance accounts for 23%, and output quality accounts for 24%. These three predictors account 
for 67% of the variance effect on PU. The variance effects on the TAM variables of PU and 
intention to use are also within range of the variance found in the initial study in which the TAM2 
was validated (Venkatesh & Davis, 2000). Hospital factors’ small moderation effect on the 
relationship between intention to use and adoption was 7%. Thus, hospital factors (costs, value 
analysis, etc.) can have a small positive effect on surgeons adopting the technology. 
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V.6 Additional Findings 
 This section elaborates on significant findings that were not hypothesized. Despite a lack 
of measurable outcomes for these findings, they could provide additional insight into the research. 
This overview denotes any findings concerning their relationship with the dependent variable of 
perceived usefulness.  
 
V.6.1 Technology Readiness Index (TRI)  
 The Technology Readiness Index (TRI) was developed by Parasuraman (2000) to measure 
one’s motivations that may promote or minimize the adoption of new technologies. The developed 
scale measures dimensions of optimism, innovativeness, discomfort, and insecurity concerning 
various technological products. Comparing the TRI to perceived usefulness could serve as a 
valuable validation measure. If a surgeon has a high TRI score, then there may be a positive 
correlation with perceived usefulness and potentially positive link to adopting the technology. 
Capturing this measurement scale could lead to further research concerning surgeon's adoption of 
technology. Questions for the TRI were included in the survey study and can be found in Appendix 
A.  
Reliability regards the internal consistency of items within the construct, which is measured 
via Cronbach’s alpha. As a result, the TRI shows internal consistency with a value of 0.83. 
Parasuraman (2000) showed a range of consistency within the construct of 0.74 – 0.81. 
Correlation analysis was also conducted to determine the strength and direction of the 
linear relationship between perceived usefulness. Using SPSS, a bivariate calculation was 
performed to determine the direction (Spearman’s Rho correlation) and strength of the 
relationships (the size of the value of the correlation coefficient). Strength is determined by the 
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correlation reflecting either 0 (no relationship), 1 (positive relationship) or -1 (negative 
relationship). The relationship between TRI and perceived usefulness was investigated using 
Spearman’s Rho coefficient, which found a strong, positive correlation between the two variables, 
r = 0.56, n = 100, p < 0.001, with high levels of TRI associated with perceived usefulness. 
Linear regression was performed to determine the ability of the TRI to predict perceived 
usefulness. Preliminary analyses were conducted to ensure no violation of the assumptions of 
normality, linearity, multicollinearity, and homoscedasticity. The total variance explained by the 
model as a whole was 20%, F(1,98) = 25.92, p < 0.001. See Tables 26 – 28 below. 
 
Table 26 TRI Model Summary 
Model R R2 Adjusted R2 
Std. Error of 
the Estimate 
1 0.46a 0.21 0.20 2.87 
a. Predictors: (Constant), TRI 
  
 
Table 27 TRI ANOVA 
Model 
Sum of 
Squares df Mean Square F p 
1 Regression 213.08 1 213.08 25.92 .00a 
Residual 805.67 98 8.22   
Total 1018.75 99    
Dependent Variable: PU 
a. Predictors: (Constant), TRI 
 
 
Table 28 TRI Coefficient 
Model 
  
T p B SE Beta 
1 (Constant) 6.83 1.74 - 3.93 0.00 
TRI 0.33 0.07 0.46 5.09 0.00 
a. Dependent Variable: PU 
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 These results show that there is a strong relationship between the TRI and perceived 
usefulness, and additional research efforts would help further define this phenomenon. 
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VI CHAPTER 6: DISCUSSION 
 This research aimed to study the behavioral intentions of surgeons in adopting clinical 
technology, more specifically, spine surgeons’ adoption of 3DP implants. The TAM2 was utilized 
to test which behavioral intentions were significant while testing for additional 
environmental/economic factors that may additionally influence the model. The TAM has been 
extensively studied, few studies on adoption within healthcare. Unfortunately, there has been a 
dearth of application of the TAM or any of its subsequent models (e.g., TAM2, UTAUT, etc.) to 
the adoption patterns for clinicians concerning adopting surgical technologies.  
 By studying the various social and cognitive factors that can influence a surgeon’s 
behavioral intent, subjective norms, job relevance, and output quality were determined to 
contribute 66% of the variance in the behavioral intent of perceived usefulness. These three 
constructs were expected to reflect a positive relationship with a surgeon’s perceived usefulness 
of the technology.  
For subjective norms, it is within reason to assume that its relationship with perceived 
usefulness and intention to use are due to a surgeon’s influences from others. As discussed earlier 
in the theoretical framework, SN pertains to one’s perception that most people who are important 
to him/her think that they should or should not perform the behavior in question (Fishbein & Ajzen, 
1975). Surgeons are influenced by other surgeons throughout their careers, from residency and 
fellowship to post-training. After training, they continue to seek input from other surgeons within 
their hospital practice or by attending surgeon conferences to engage in evidence-based practice. 
This often involves analyzing the literature on technologies used and the clinical impact of these 
devices. 3DP implants are currently heavily promoted at surgeon conferences via corporations and 
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surgeon panel discussions. Thus, these influences undoubtedly shape a surgeon’s perception of a 
technology’s usefulness and their subsequent intention to adopt. 
 The relationship of job relevance on perceived usefulness represents another predictor of 
surgeon behavior. JR is defined as one’s perception of the degree to which the target system (in 
this case, 3DP implant technology) applies to their job (Venkatesh & Davis, 2000). The use of 
3DP implants provide the same clinical application as older technologies (PEEK versions) and 
allow the surgeon to restore spinal alignment. These 3DP implants are thus strongly relevant to the 
job focus and within a surgeons’ domain of expertise usage. 
 Output quality is another predictor that is capable of predicting surgeon behavior and is 
defined as one’s perception of the degree to which the target system (in this case, 3DP implant 
technology) performs tasks related to their job relevance. This finding is also not surprising since 
output quality relates to a surgeon’s determination to use a technology if it improves their 
procedural workflow or patient clinical outcomes. To improve a surgeon’s procedural workflow, 
technology must be reproducible and minimize the potential for errors, and clinical efficacy and 
outcomes also need to be improved with the technology. 3DP implants can improve workflow in 
some instances, such as a custom implant that closely matches the patient’s anatomy, which in turn 
minimizes the necessary prep work that a standard off-the-shelf PEEK or titanium block implant 
might require for insertion (Kim et al., 2017; Ventola, 2014). 3DP implants can also provide 
improved efficacy and outcomes since the material and structure may provide improved fusion 
rates compared to PEEK implants. The goal is for these implants is to provide the quickest and 
most efficient rate of fusion while providing stability to the spinal column (Seaman et al., 2017). 
Current research favorably views 3DP implants, and thus it is no surprise that spine surgeons are 
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influenced via this construct (Brown, 2017; Garg & Mehta, 2018; Kim et al., 2017; Lal & 
Pratralekh, 2018; McGilvray et al., 2018; Mobbs et al., 2017; Mok et al., 2016; Tack et al., 2016).  
 The 72% variance in behavioral intent of “intention to use” was determined to be 
comprised of 28% contribution from perceived usefulness and 44% from perceived ease of use. 
This variance is aligned with results of previous TAM studies that have shown similar variance 
rates between 60–70% (Liang et al., 2003; Schaper & Pervan, 2007; Tung et al., 2008; Wu et al., 
2007). The consistency of these findings with prior research utilizing the TAM to measure 
physician technology adoption in other fields suggests the TAM2 is a valid model to measure 
behavioral intents by surgeons when measuring the adoption of clinical technologies. However, 
other factors relevant to clinical practice may help elucidate surgeon technology adoption.   
 SN, JR, OQ, PU, PEOU, and IU suggest positive relationships and can be predictors of 
surgeons’ intention to adopt a technology. However, other variables that did not show a statistical 
relationship include image, results demonstrability, loyalty, and voluntariness. 
 It can be postulated that image is not a factor since it is defined as the degree to which the 
use of an innovation is perceived to enhance one’s image or status in one’s social system (Moore 
& Benbasat, 1991). Surgeons do not adopt technologies based on improving their image but 
instead choose technologies that will improve the procedure or clinical outcomes for the patient. 
They are also not swayed by others’ usage unless there are clinical outcomes to highlight the 
benefit of the technology.  
 Results demonstrability is not a predictor that influences surgeon adoption, and it is defined 
as one’s ability to understand results provided by the technology and one’s ability to communicate 
this understanding to others. Surprisingly, there was no relationship with perceived usefulness; 
however, there often may be conflicting information regarding the benefits of new technology. 
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There may be insufficient clinical outcome studies to show the technology’s specific benefits, and 
thus surgeons may not have established a firm belief in the technology. It would be interesting to 
observe whether this result changes with a larger sampling of spine surgeons.  
 Another surprising outcome was that loyalty had no moderating effect on the relationship 
between SN and PU, as well as no moderating effect on the relationship between SN and IU. This 
outcome is unexpected since spine surgeons develop close relationships with their local sales 
representative and view the sales representative as a consultant who provides the necessary 
equipment and devices that allow them to operate successfully. There are instances in which the 
sales representative resigns from one organization to sell products for a different organization, but 
only if their surgeon customer agrees that he can utilize the new organization’s equipment. Thus, 
exhibiting a clear example of loyalty from the sales representative. Also, some surgeons are 
consultants for medical device companies helping to design new products, leading one to assume 
that such a surgeon would prefer their organization’s products. Surgeons ultimately utilize 
products and technology in which they believe and utilize multiple products from different 
companies within their armamentarium of surgical tools. Their loyalty is to the patient, which 
supersedes loyalty to the sales representative, company, or hospital. 
 The voluntariness construct showed no moderating effect on the relationship between SN 
and IU. Voluntariness measures the extent to which a potential adopter perceives the adoption 
decision to be non-mandatory (Venkatesh & Davis, 2000). It was originally proposed that this 
construct would impact surgeons’ intention to use since environmental factors could influence 
surgeons. Examples include other surgeons’ in the hospital adoption of the technology, or 
medically informed patients request for the usage of such technology, who may otherwise find a 
surgeon who does utilize them. Upon reflection, surgeons always have a choice of technologies to 
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use and employ technologies that are familiar and have proven to provide them with satisfactory 
outcomes. Although some hospital organizations may have a limited vendor policy and require 
surgeons to use products and devices from a limited number of medical device manufacturers, they 
never force a surgeon to adopt new technology. On the contrary, hospitals would prefer to limit 
new technology adoption since it often entails a substantial increase in costs to the hospital.  
 Interestingly, the relationship between intention to use and adoption of 3DP implants was 
negative, which implies that the intention to use these implants does not necessarily lead to 
adoption. However, this result was not statistically significant (p-value of 0.06) and could be due 
to the fact that, although the surgeon intends to utilize 3DP implants, another factor impacts this 
adoption. It should be noted that of the 100 spine surgeons that completed the research survey, 74 
had officially adopted 3DP implants in their practice. The final factor that somewhat influences 
3DP implant adoption regards hospital factors, which showed a small moderating effect on the 
relationship between IU and the adoption of 3DP implants. This relationship was found to have a 
7% variance effect on the relationship, and therefore hospital influences have affected the adoption 
rates. Hospitals control which vendors have access to their facilities in an attempt to control costs 
and inventory (Gelijns & Halm, 1991), which ultimately impacts the financial stability of many 
hospitals (Vizient, 2019). It is assumed that as more clinical data are obtained regarding the clinical 
efficacy and outcomes of 3DP implants, hospitals will favorably welcome their addition since they 
could provide procedural and workflow improvements as well as improved patient outcomes.  
 Overall, the resultant empirically supported model (TAM2-C) highlights that the intrinsic 
behaviors that influence surgeon adoption of technology includes social influence of subjective 
norms and cognitive influences of job relevance and output quality. Although the tested sampling 
of surgeons showed significant resultant TAM variables of perceived usefulness, perceived ease 
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of use, and intention to use behaviors, their adoption of 3DP implants was moderated by hospital 
factors. Albeit a small relationship, this result theoretically supports the existing industry process 
whereby hospitals wish to exert control over the adoption of technology within their facilities. 
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VII CHAPTER 7: CONTRIBUTIONS, LIMITATIONS, FUTURE RESEARCH & 
CONCLUSION 
VII.1 Implications for Researchers 
Many researchers have investigated the behaviors of clinicians’ acceptance of technology 
concerning IT healthcare applications (Ratten, 2015; Nagy, 2018; Escobar-Rodriguez, 2012). 
While the TAM has been extensively studied and validated to show that usefulness and ease of use 
are mediators to one’s intention to use a technology (Venkatesh, 1999), there has been no attempt 
to apply TAM or subsequent models to non-IT related technologies. This research application 
suggests that the TAM is a useful model for measuring surgeons’ behaviors towards the clinical 
adoption of technology, which in this case, is 3DP implants used for spinal procedures. Also, this 
study extends previous research by investigating the TAM2’s use in clinicians’ technology 
adoption since it has been used in an IT healthcare technology adoption study (Chismar & Wiley-
Patton, 2003). Finally, this research contributes to the TAM framework by investigating other 
environmental/economic variables that the TAM has not accounted for in previous studies. 
Although loyalty was shown to lack a moderation influence, hospital factors showed a small 
moderating influence on the relationship between intention to use and adoption. This relationship 
should be further investigated and validated. 
 
VII.2 Implications for Practitioners 
Subjective norms constitute 37% of the adoption variance, thus contributing more to the 
effect on perceived usefulness than job relevance and output quality. While subjective norm is a 
social influencing variable, it can give companies guidance or provide support for continuing 
existing strategies that target or influence potential users. Companies could implement marketing 
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campaigns that expand beyond typical sales collateral provided to surgeons by sales 
representatives or advertising utilized at surgeon conferences. By looking to other industries, 
medical device companies could use more behavioral marketing to further influence surgeon 
perceptions of perceived usefulness of new clinical technology. By utilizing digital marketing 
techniques from other industries, the medical device industry could further improve their 
marketing to include aspects of behavioral marketing. Numerous strategies could involve a more 
robust, interactive website strategy that goes further than just showing product images and features 
and benefits. Improvements could involve interactive links to further determine what information 
the surgeon is seeking to help influence their behavior. From this website improvement, data can 
be collected to help determine what information is most impactful. Another strategy could involve 
implementing social influence campaigns that target a surgeon influencer’s network (Risselada, 
2014). For example, companies could create educational pieces that surgeon key opinion leaders 
would post to social networks such as LinkedIn that highlight the clinical benefits of the product 
coupled with surgeon and/or patient testimonials. Also, utilizing new virtual conference call 
programs, surgeon to surgeon training courses could be utilized to extend the reach of influence 
by these key opinion leaders.  Previous research validates that an individual’s social network 
includes others similar to themselves, who tend to have opinion leaders or revenue leaders 
influencing their network (Haenlein & Libai, 2013). Marketing activities should be targeted 
towards these key opinion and revenue leaders since they could provide positive subjective norm 
influence on others. Finally, corporations or marketers could utilize this research by creating 
marketing strategies to influence the components of hospital influences. This should entail a dual 
approach of impacting subjective norms and hospital influencers since both can impact technology 
adoption. 
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Corporations can also implement more robust marketing to influence surgeons’ subjective 
norms and hospital influences while highlighting the job relevance and output quality of the 
technology.  Corporations can use this research to determine secondary strategies for the other 
variables that did not prove to have significant influence. Loyalty and result demonstrability could 
receive focus strategically after implementing plans for addressing the core variables of subjective 
norm, job relevance, and output quality. 
 
VII.3 Limitations 
It is essential to recognize the assumptions and limitations that can affect the accuracy of 
the research results. Several assumptions were made regarding this study, such as that participants 
had access to technical knowledgebases and were familiar with the terms presented in the survey. 
Another assumption was that participants would answer the survey questions truthfully and 
completely, and it was further assumed that this researcher would receive sufficient survey returns 
to measure the desired outcomes effectively.  
One potential limitation is self-selection bias. Given the voluntary nature of the survey, 
surgeons who are interested in using or have used newer technology (3D-printed implants) for 
surgery may have been more likely to respond. Self-reporting bias could also have impacted the 
results if respondents did not feel comfortable accurately reporting their feelings, attitudes, and 
behaviors. Methods bias can also negatively affect results in studies relying on one type of data 
input.   
The measurement of hospital factors could have limited validity because some surgeon 
respondents may have limited knowledge of institutional factors.  Engaging hospital executives to 
answer the survey questions regarding hospital factors and cross-referencing these responses with 
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surgeons’ answers may improve accuracy. Another limitation is the limited number of 
international surgeon respondents; additional international surgeons could further determine 
whether there are impacts on adoption, which statistically vary by country.  
Although the loyalty and hospital factor constructs were utilized in this research, further 
research is required to validate these results. The results could be strengthened by employing the 
Churchill (1979) reliability standard to validate the two constructs. 
Finally, another limitation of this study is the sampling method.  Purposive sampling could 
have resulted, which may not be representative of the population due to the potential subjectivity 
of the employed research collection methods.  
 
VII.4 Future Research 
 Further research with a larger sample size can help to validate the constructs of loyalty 
and hospital factors. There are also opportunities to identify other clinical environmental factors 
that may influence surgeon adoption behavior. Factors such as technology costs or training 
variables required for learning new technology could also be studied concerning adoption and 
behavioral inputs. Finally, future research could validate the different versions of TAM (e.g., 
TAM2, TAM3, UTAUT) to determine whether one represents a more suitable model for 
measuring surgeons’ clinical adoption of technology.  
 
VII.5 Conclusion 
The purpose of this research was to study factors that influence surgeons’ behavioral 
intent to adopt technology for clinical use in surgery as measured by the theoretical framework 
of the TAM2. This study specifically examined spine surgeons and their adoption of 3D-printed 
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implants for spinal surgeries. The findings suggest that the surgeon factors of subjective norms, 
job relevance, and output quality have a positive impact on surgeons’ perceived usefulness, 
which impacts their intention to use the technology. Their intention subsequently led to the 
adoption of 3D-printed implants; however, environmental and economical hospital factors 
provide a small moderating effect on the adoption. It was discovered that variables expected to 
have influence (loyalty, voluntariness, image, and results demonstrability) were determined to 
have no impact on surgeon behavior.  
 Medical device innovation will continue to proliferate, and companies developing these 
technologies will need to continually re-evaluate how they influence the end-user to adopt them. 
The TAM2 helped to determine that subjective norms influence a surgeons’ behavioral intent to 
adopt technology. Therefore, organizations should draft executable strategies that target their 
technologies towards surgeons’ subjective norms while also highlighting how the technology 
appeals to their perceived usefulness and perceived ease of use. Finally, companies will need to 
continue to help educate and influence hospitals concerning their technologies since the hospitals 
will moderate the adoption practices of surgeons. 
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APPENDICES 
Appendix A. Survey Instrument 
 
  
 
 
 
 
Experience (E) 
Specialty (S): What is your specialty?  
a. Orthopedics - 2 
b. Neurosurgery - 1 
c. Non-applicable - 0 
 
Clinical Position (CP): Please select your current clinical status 
a. Attending Surgeon - 4 
b. Fellow - 3 
c. Chief Resident - 2 
d. Resident - 1 
 
Clinical Focus (Complex, DG, MI) (CF): Please select all that apply regarding your spine clinical 
focus 
a. Degenerative - 1 
b. Complex - 1 
c. Minimally Invasive - 1 
d. Pediatrics - 1 
 
Clinical Tenure (CT): Please select how many years you have been a practicing surgeon 
a. 0 – 5 - 1 
b. 6 – 10 - 2 
c. 11 – 15 - 3 
d. 16 – 20 - 4 
e. 21 – 25 - 5 
f. 26 – 30 - 6 
g. 31 – 35 - 7 
h. 36+ - 8 
 
Surgical Volume (SV): Please select the average number of surgical cases you complete monthly 
a. 1 – 10 - 1 
b. 11 – 20 - 2 
c. 21 – 30 - 3 
d. 31+ - 4 
 
Surgical/Teaching Leadership (SL1): Please select all your current academic positions 
Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
1 2 3 4 5 
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a. Professor - 1 
b. Assistant Professor - 1 
c. Associate Professor - 1 
d. Other - 1 
e. Non-Applicable - 0 
 
Surgical/Teaching Leadership (SL2): Please select all activities in which you engage 
a. Teach fellows/residents - 1 
b. Write journal publications - 1 
c. Speak at extramural meetings - 1 
d. Non-applicable - 0 
 
Do you currently hold any administrative leadership roles in your hospital? 
a. Yes - 1 
b. No - 0 
 
Age (AG): Please select your age range 
a. 18 – 24 
b. 25 – 34 
c. 35 – 44 
d. 45 – 54 
e. 55 – 66 
f. 65 or older 
 
Gender (G): Please select your gender 
a. Male 
b. Female 
c. Other 
 
Using the following scale, please fill in your response to each question below. 
 
 
 
 
 
 
Perceived Usefulness (PU) 
PU1 Using technology improves my performance in surgery.  
PU2 Using technology in surgery increases my productivity.  
PU3 Using technology enhances my effectiveness in surgery.  
PU4 I find technology to be useful in surgery. 
 
Perceived Ease of Use (PEOU) 
PEOU1 My interaction with technology in surgery is clear and understandable.  
PEOU2 Interacting with technology in surgery does not require a lot of my mental effort.  
PEOU3 I find technology to be easy to use in surgery.  
Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
1 2 3 4 5 
68 
 
PEOU4 I find it easy to get technology to do what I want it to do in surgery.  
 
 
Intention to Use (IT)  
IT1 Assuming I have access to technology, I intend to use it in surgery.  
IT2 Given that I have access to technology, I predict that I would use it in surgery.  
 
Subjective Norm (SN) 
SN1 People who influence my behavior think that I should use technology in surgery.  
SN2 People who are important to me think that I should use technology in surgery.  
 
Voluntariness (V) 
V1 My use of technology in surgery is voluntary.  
V2 My supervisor does not require me to use technology in surgery.  
V3 Although it might be helpful, using technology is certainly not compulsory in surgery.  
 
Image (I) 
I1 People in my hospital who use technology in surgery have more prestige than those who do 
not.  
I2 People in my hospital who use technology in surgery have a high profile.  
I3 Using technology during surgery is a status symbol in my hospital.  
 
Job Relevance (JR) 
JR1 In my job, usage of technology in surgery is important.  
JR2 In my job, usage of technology in surgery is relevant.  
 
Output Quality (OQ) 
OQ1 The quality of the output I get from the technology during surgery is high.  
OQ2 I have no problem with the quality of the technology's output during surgery.  
 
Result Demonstrability (RD) 
RD1 I have no difficulty telling others about the results of using the technology in surgery.  
RD2 I believe I could communicate to others the consequences of using the technology in 
surgery.  
RD3 The results of using the technology in surgery are apparent to me.  
RD4 I would have difficulty explaining why using the technology in surgery may or may not be 
beneficial.  
 
Loyalty Influence (LI)  
Using the following scale, please fill in your response to each question below. 
 
 
 
 
 
 
Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
1 2 3 4 5 
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LI1 I prefer surgical products from a particular manufacturer/vendor. 
LI2 I utilize surgical products based on my local sales representative relationship. 
LI3 Do you have any corporate teaching, consulting, and/or product development contracts 
within the spine industry? 
a. Yes - 1 
b. No - 0 
LI4 Please select all that apply with respect to your manufacturer/vendor relationships 
a. Receive Consulting fees - 1 
b. Receive Patent Royalties - 1 
c. Receive Honoraria for talks, teaching, etc. – 1 
d. Non-Applicable - 0 
 
 
Using the following scale, please fill in your response to each question below. 
 
 
 
 
 
 
Technology Readiness Index (TRI) 
New technologies contribute to a better quality of life.       
Technology gives people more control over their lives. 
Technology makes people more productive. 
Other people come to me for advice on new technologies. 
In general, I am among the first in my circle of friends to acquire new technology when it 
appears.  
I can usually figure out new high-tech products and services without help from others. 
I keep up with the latest technological developments in my area. 
 
Hospital Factors (HF) Please select the choices that best describe the primary hospital in 
which you perform greater than 75% of your surgical procedures: 
HF1 My hospital has reduced the number of product vendors. 
HF2 My hospital’s purchasing staff approves all technology requests. 
HF3 The cost of new technology influences our hospital’s decision to acquire that particular 
technology. 
HF4 I have influence on hospital vendor selection. 
HF5 My hospital is restricting access to vendors of innovative technologies. 
HF6 My hospital requires me to utilize innovative technologies from only select vendors. 
HF7 Value analysis or new technology committees in the hospital influence my decision to use a 
given innovative technology or work with a given vendor. 
HF8 Reimbursement rates for new technology will influence my use of the technology. 
HF9 Reimbursement rates for new technology will influence my hospital’s approval of the 
technology. 
 
Strongly 
Disagree 
Disagree Neutral Agree Strongly 
Agree 
1 2 3 4 5 
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Please select all that describes the primary hospital in which you perform greater than 75% of 
your surgical procedures: 
 
HFD1 System Membership (SM) 
a. Academic - 1 
b. Community - 1 
c. Health System Affiliated 
d. Non-Health System Affiliated 
e. Veterans’ Health Administration/Military  
f. I do not know 
 
HFD2 Hospital Size (# of Beds) (HS) 
a. 1-100 
b. 101-200 
c. 201-500 
d. 500+ 
e. I do not know 
 
HFD3 Tax Status (TS) 
a. Profit 
b. Non-Profit 
c. I do not know 
 
HFD4 Geographic Location (GL) 
a. Urban 
b. Suburban 
c. Rural 
 
HFD5 State Location (S): Enter State 
 
Surgeon Adoption (SA) 
SA1 Have you adopted any of the following technologies in the last year for surgical use? Check 
all that apply 
a. 3D Printed Implants - 1 
b. Robotic technology - 1 
c. MIS Navigation - 1 
d. Other - 1 
 
SA2 If you have not adopted any 3D printed implants in the last year for surgical use, check all 
that apply as to your reason for not adopting 
a. High cost - 1 
b. Reimbursement issues - 1 
c. No perceived clinical benefit - 1 
d. Negative clinical outcomes - 1 
e. No perceived time savings in the surgical suite - 1 
f. High learning curve - 1 
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g. Limited scope of usability - 1 
h. Other - 1 
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Appendix B. Validity Statistics 
 
 
Table B1 
 
 
Validity Statistics for TAM-C Survey Items 
     
      
Item n Min Max M SD 
Using technology improves my performance in 
surgery 
100 1 5 3.92 0.884 
Using technology in surgery increases my 
productivity 
100 1 5 3.61 0.994 
Using technology enhances my effectiveness in 
surgery 
100 1 5 3.87 0.928 
I find technology to be useful in surgery 100 1 5 4.15 0.809 
My interaction with technology in surgery is clear 
and understandable 
100 1 5 3.93 0.795 
Interacting with technology in surgery does not 
require a lot of my mental effort 
100 1 5 3.32 1.171 
I find technology to be easy to use in surgery 100 1 5 3.86 0.899 
I find it easy to get technology to do what I want it to 
do in surgery 
100 1 5 3.72 0.933 
Assuming I have access to technology, I intend to 
use it in surgery 
100 1 5 3.94 0.930 
Given that I have access to technology, I predict that 
I would use it in surgery 
100 2 5 4.07 0.844 
People who influence my behavior think that I 
should use technology in surgery 
100 1 5 3.06 0.983 
People who are important to me think that I should 
use technology in surgery 
100 1 5 3.14 0.995 
My use of technology in surgery is voluntary 100 1 5 4.45 0.657 
My supervisor does not require me to use technology 
in surgery 
100 1 5 4.27 0.839 
Although it might be helpful, using technology is 
certainly not compulsory in surgery 
100 1 5 4.17 0.954 
People in my hospital who use technology in surgery 
have more prestige than those who do not 
100 1 5 2.75 1.132 
People in my hospital who use technology in surgery 
have a high profile 
100 1 5 3.01 1.105 
Using technology during surgery is a status symbol 
in my hospital 
100 1 5 2.65 1.114 
In my job, usage of technology in surgery is 
important 
100 1 5 4.00 0.888 
In my job, usage of technology in surgery is relevant 100 1 5 4.09 0.866 
The quality of the output I get from the technology 
during surgery is high 
100 1 5 3.75 0.821 
I have no problem with the quality of the 
technology's output during surgery 
100 1 5 3.57 0.987 
I have no difficulty telling others about the results of 
using the technology in surgery 
100 2 5 4.31 0.706 
I believe I could communicate to others the 
consequences of using the technology in surgery 
100 2 5 4.35 0.657 
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Table B1 
Continued 
      
Item n Min Max M SD 
The results of using the technology in surgery are 
apparent to me 
100 1 5 3.99 0.859 
I would have difficulty explaining why using the 
technology in surgery may or may not be beneficial 
100 1 5 2.27 1.062 
I prefer surgical products from a particular company 100 1 5 3.39 0.931 
I utilize surgical products based on my local sales 
representative relationship 
100 1 5 3.19 1.107 
Do you have any corporate teaching, consulting 
and/or product development contracts within the 
spine industry? 
100 1 2 1.41 0.494 
Manufacturer/vendor relationships Receive 
consulting fees 
100 0 1 0.46 0.501 
Manufacturer/vendor relationships Receive patent 
royalties 
100 0 1 0.38 0.488 
Manufacturer/vendor relationships Receive honoraria 
for talks, teaching, etc. 
100 0 1 0.44 0.499 
Manufacturer/vendor relationships Non-applicable 100 0 1 0.40 0.492 
My hospital has reduced the number of product 
vendors 
100 1 5 3.48 1.235 
My hospital’s purchasing staff approves all 
technology requests 
100 1 5 3.33 1.264 
The cost of new technology influences our hospital’s 
decision to acquire that particular technology 
100 1 5 4.30 0.785 
I have influence on hospital vendor selection 100 1 5 3.74 1.031 
My hospital is restricting access to vendors of 
innovative technologies 
100 1 5 3.18 1.184 
My hospital requires me to utilize innovative 
technologies from only select vendors 
100 1 5 2.86 1.146 
Value analysis or new technology committees in the 
hospital influence my decision to use a given 
innovative technology 
100 1 5 3.53 1.049 
Reimbursement rates for new technology will 
influence my use of the technology 
100 1 5 3.10 1.193 
Reimbursement rates for new technology will 
influence my hospital’s approval of the technology 
100 1 5 3.93 1.037 
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Appendix C. Descriptive Statistics 
 
Table C1 
 
 
Descriptive Statistics for TAM-C Survey Items 
     
      
Item n Min Max M SD 
Using technology improves my performance in 
surgery 
100 1 5 3.92 0.88 
Using technology in surgery increases my 
productivity 
100 1 5 3.61 0.99 
Using technology enhances my effectiveness in 
surgery 
100 1 5 3.87 0.93 
I find technology to be useful in surgery 100 1 5 4.15 0.81 
My interaction with technology in surgery is clear 
and understandable 
100 1 5 3.93 0.79 
Interacting with technology in surgery does not 
require a lot of my mental effort 
100 1 5 3.32 1.17 
I find technology to be easy to use in surgery 100 1 5 3.86 0.90 
I find it easy to get technology to do what I want it to 
do in surgery 
100 1 5 3.72 0.93 
Assuming I have access to technology, I intend to 
use it in surgery 
100 1 5 3.94 0.93 
Given that I have access to technology, I predict that 
I would use it in surgery 
100 2 5 4.07 0.84 
People who influence my behavior think that I 
should use technology in surgery 
100 1 5 3.06 0.98 
People who are important to me think that I should 
use technology in surgery 
100 1 5 3.14 0.99 
My use of technology in surgery is voluntary 100 1 5 4.45 0.66 
My supervisor does not require me to use technology 
in surgery 
100 1 5 4.27 0.84 
Although it might be helpful, using technology is 
certainly not compulsory in surgery 
100 1 5 4.17 0.95 
People in my hospital who use technology in surgery 
have more prestige than those who do not 
100 1 5 2.75 1.13 
People in my hospital who use technology in surgery 
have a high profile 
100 1 5 3.01 1.10 
Using technology during surgery is a status symbol 
in my hospital 
100 1 5 2.65 1.11 
In my job, usage of technology in surgery is 
important 
100 1 5 4.00 0.89 
In my job, usage of technology in surgery is relevant 100 1 5 4.09 0.87 
The quality of the output I get from the technology 
during surgery is high 
100 1 5 3.75 0.82 
I have no problem with the quality of the 
technology's output during surgery 
100 1 5 3.57 0.99 
I have no difficulty telling others about the results of 
using the technology in surgery 
100 2 5 4.31 0.71 
I believe I could communicate to others the 
consequences of using the technology in surgery 
100 2 5 4.35 0.66 
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Table B1 
Continued 
      
Item n Min Max M SD 
The results of using the technology in surgery are 
apparent to me 
100 1 5 3.99 0.86 
I would have difficulty explaining why using the 
technology in surgery may or may not be beneficial 
100 1 5 2.27 1.06 
I prefer surgical products from a particular company 100 1 5 3.39 0.93 
I utilize surgical products based on my local sales 
representative relationship 
100 1 5 3.19 1.11 
Do you have any corporate teaching, consulting 
and/or product development contracts within the 
spine industry? 
100 1 2 1.41 0.49 
Manufacturer/vendor relationships Receive 
consulting fees 
100 0 1 0.46 0.50 
Manufacturer/vendor relationships Receive patent 
royalties 
100 0 1 0.38 0.49 
Manufacturer/vendor relationships Receive honoraria 
for talks, teaching, etc. 
100 0 1 0.44 0.50 
Manufacturer/vendor relationships Non-applicable 100 0 1 0.40 0.49 
My hospital has reduced the number of product 
vendors 
100 1 5 3.48 1.23 
My hospital’s purchasing staff approves all 
technology requests 
100 1 5 3.33 1.26 
The cost of new technology influences our hospital’s 
decision to acquire that particular technology 
100 1 5 4.30 0.79 
I have influence on hospital vendor selection 100 1 5 3.74 1.03 
My hospital is restricting access to vendors of 
innovative technologies 
100 1 5 3.18 1.18 
My hospital requires me to utilize innovative 
technologies from only select vendors 
100 1 5 2.86 1.15 
Value analysis or new technology committees in the 
hospital influence my decision to use a given 
innovative technology 
100 1 5 3.53 1.05 
Reimbursement rates for new technology will 
influence my use of the technology 
100 1 5 3.10 1.19 
Reimbursement rates for new technology will 
influence my hospital’s approval of the technology 
100 1 5 3.93 1.04 
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